Health
Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers – News-Medical.Net
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly…
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
Business24 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%
-
General23 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General16 hours agoPhotographers reveal iconic image of Gough Whitlam and Vincent Lingiari was posed on Wave Hill Walk-Off anniversary
-
Noosa News14 hours agoDog daycare program a TikTok hit for helping disabled find work, friends